Top Stories
-
In this Q&A, Edmond Chan discusses his current work on synthetic lethality, including an ongoing clinical trial and major new basic research findings.
Topic
-
Explore pioneering work in AI, cell therapy and immunotherapy, and our approach to compassionate, community-informed care in the 2024 Pathways to a Cure annual report.
Topic
-
A Columbia clinical trial led by Hua-Jay Cherng, MD, will partner with Foresight Diagnostics to evaluate more personalized cancer treatments for patients with diffuse large B-cell lymphoma (DLBCL)..
Topic
-
Columbia physician-scientist Ryan Moy, MD, PhD, is pioneering research in gastric cancer, including a promising new clinical trial using pill-based therapies to treat diffuse gastric cancer.
Topic
Latest News
- August 19, 2024
Study led by Melissa Beauchemin, PhD, highlights that inadequate translation and interpretation services in the U.S. contributes to lack of representation in cancer clinical trials.
Topic
- March 4, 2024
Experts reviewed withdrawals across fast-track drug approval programs, finding that overall, these programs contribute positively to drug development with little safety concerns.
Topic
-
Source:
Department of PediatricsMarch 13, 2023A team of Columbia physician-scientists have opened a trial of a noninvasive, focused ultrasound approach to open the blood-brain barrier to better treat pediatric brain tumors.
Topic
- February 28, 2023
Tannishtha Reya, PhD, is establishing the new Irving Cancer Drug Discovery Program, devoted to helping faculty accelerate research discoveries in their labs to the clinic.
Topic
- December 19, 2022
Exciting new clinical investigations, including results of the ALPINE study, show promising, more effective treatment for patients with CLL.
Topic
- November 30, 2022
Peter encourages others to look into clinical trials and not lose hope.
Topic
-
Source:
CUIMC NewsroomNovember 10, 2022Dr. Jeffrey Bruce: "This new approach has the potential to transform treatment for patients with brain cancer, where the outlook for survival remains very poor."
Topic
- November 3, 2022
Results of a multi-center study, co-led by Dr. Richard Carvajal, demonstrates a promising new immunotherapy for patients with rare uveal melanoma.
Topic
- October 25, 2022
Melissa Accordino, MD, tackles solutions to long-term side effects, like peripheral neuropathy, that some breast cancer survivors experience after overcoming the disease.
- September 26, 2022
During First Lady Jill Biden's Columbia Sept. 21 visit, she singles out patient, Mario Sambula and his special connection with clinical trials nurse navigator, Brianne Bodin.
Topic
